| Hidradenitis Suppurativa |
1 |
0.78 |
| Skin and Soft Tissue Infection |
0 |
0.78 |
| Insurance |
0 |
0.56 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.56 |
| Tumor |
0 |
0.56 |
| Biologic Therapy |
0 |
0.47 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.39 |
| HIV Infection |
0 |
0.39 |
| Revenue and Practice Management |
0 |
0.39 |